Table 2. Nasal Obstruction Symptom Evaluation Scores of Studies Analyzed.
| Source | Mean (SD) | Cohort Size, No. |
|---|---|---|
| Barham et al,17 2015 | ||
| Change in score for entire samplea | −30.25 (25.33) | 41 |
| Change in score for cephalic turn-in maneuver | −29.73 (23.05) | 25 |
| Change in score for costal cartilage grafts | −31.25 (25.33) | 16 |
| Chambers et al,18 2015 | ||
| Baseline score | 75.7 (20.1) | 40 |
| Score at 2 mo | 31.4 (27.2) | 40 |
| Score at 4 mo | 34.0 (19.8) | 40 |
| Score at 6 mo | 22.1 (18.8) | 40 |
| Deroee et al,19 2011 | ||
| Change in score | −40.4 (7.9) | 12 |
| Egan and Kim,16 2005 | ||
| Baseline score | 67.1 (10.4) | 6 |
| Postoperative score | 18.6 (14.6 | 6 |
| Score at 3 mo | 21.4 (15.2) | 6 |
| Lindsay,4 2012 | ||
| Entire sample | ||
| Baseline score | 66.42 (20.25) | 60 |
| Score at 1-3 mo | 21.85 (20.68) | 54 |
| Score at 6-12 mo | 22.33 (23.05) | 45 |
| Internal nasal valve | ||
| Baseline score | 61.79 (23.34) | 14 |
| Score at 1-3 mo | 13.46 (19.19) | 13 |
| Score at 6-12 mo | 4.09 (7.35) | 11 |
| External nasal valve | ||
| Baseline score | 59.69 (20.69) | 16 |
| Score 1-3 mo | 22.69 (15.22) | 13 |
| Score 6-12 mo | 18.85 (17.34) | 13 |
| Both valves | ||
| Baseline score | 72.17 (17.30) | 30 |
| Score at 1-3 mo | 25.36 (22.93) | 28 |
| Score at 6-12 mo | 34.05 (25.03) | 21 |
| Palesy et al,20 2015 | ||
| Change in score | −30.53 (26.14) | 19 |
| Rhee et al,21 2005 | ||
| Baseline score | 68.9 (20.9) | 20 |
| Score at 3 mo | 20.7 (19.5) | 14 |
| Score at 6 mo | 15.8 (18.2) | 20 |
| Roofe and Most,22 2007 | ||
| Baseline score | 65.0 (7.6) | 8 |
| Score at 6 mo | 19.0 (18.9) | 8 |
| Change in 4 mob | −46.0 (16.53) | 42 |
| Sufyan et al 2012c | ||
| Tan and Rotenberg,24 2012d | ||
| Baseline score | 86.5 (8.0) | 15 |
| Score at 11 mo | 26.5 (11.5) | 15 |
| Yeung et al,25 2016b | ||
| Change at 3 mo for entire sample | −48.6 (29.93) | 79 |
| Change at 3 mo for functional | −51.4 (26.42) | 31 |
| Change at 3 mo for aesthetic-functional | −46.6 (33.58) | 48 |
a
Standard deviation adopted from reported postoperative standard deviation (costal cartilage grafts group).
b
Standard deviations were calculated from reported 95% confidence intervals.
c
No data needed for effect size calculation reported.
d
The Nasal Obstruction Symptom Evaluation scores are reported on a 20-point scale; thus, the scores were multiplied by 5.